V
Market Data
$0.23−$0.04 (−14.59%)
VTGN · Last trade
Prev Close
$0.27
Range (30d)
$0.23 – $0.26
Recent Filings
- 8-K153.0 KBVistagen Therapeutics, Inc.Sep 10, 7:24 PM ET·0001628280-26-061445
- SCHEDULE 13G/A16.6 KBVistagen Therapeutics, Inc.Aug 14, 5:49 PM ET·0000947871-26-000804
- SCHEDULE 13G/A22.7 KBVistagen Therapeutics, Inc.Aug 14, 4:27 PM ET·0001193125-26-352371
- 10-Q5.2 MBVistagen Therapeutics, Inc.Aug 14, 4:12 PM ET·0001628280-26-057116
- SCHEDULE 13G/A15.8 KBVistagen Therapeutics, Inc.Aug 14, 4:04 PM ET·0001831942-26-000032
- 8-K241.3 KBVistagen Therapeutics, Inc.Aug 14, 8:40 AM ET·0001628280-26-056953
- 8-K204.6 KBVistagen Therapeutics, Inc.Aug 6, 4:16 PM ET·0001628280-26-054341
- 8-K138.7 KBVistagen Therapeutics, Inc.Aug 5, 4:04 PM ET·0001628280-26-053304
- 8-K250.5 KBVistagen Therapeutics, Inc.Jul 31, 8:48 AM ET·0001628280-26-051251
- 8-K1.5 MBVistagen Therapeutics, Inc.Jun 30, 8:28 AM ET·0001628280-26-046143
Insiders
10- Adler Reid G.Chief Legal Officer
- Anderson Cynthia LynnCHIEF FINANCIAL OFFICER
- Angelov Angel SChief Medical Officer
- Bonfiglio Gregory A.Director
- Cato Allen Easley10% Owner
- Commodore Capital LP10% Owner
- Cote Elissa S.Chief Corp Development Officer
- Cunningham Ann MichelleDirector
- Curley JoanneDirector
- DOTSON JERROLD DUANEVP, CFO
Tickers
Addresses
business
343 ALLERTON AVENUE
SOUTH SAN FRANCISCO, CA, 94080
mailing
343 ALLERTON AVENUE
SOUTH SAN FRANCISCO, CA, 94080
Former Names
- Excaliber Enterprises, Ltd.2011-06-08